Adenosine Deaminase Binding to Human CD26 Is Inhibited by HIV-1 Envelope Glycoprotein gp120 and Viral Particles

Journal of Immunology

Volumn 158, Issue 8, 1997, Pages 3721-3729

  Valenzuela, Agustín ^a   Blanco, Julià ^b   Callebaut, Christian ^b   Jacotot, Etienne ^b   Lluis, Carmen ^a   Hovanessian, Ara G ^b   Franco, Rafael ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; DIPEPTIDYL PEPTIDASE IV; GLYCOPROTEIN GP 120;

AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; CELL LINE; DRUG EFFECT; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PROTEIN BINDING; T LYMPHOCYTE; VIRION; VIROLOGY;

ADENOSINE DEAMINASE; AMINO ACID SEQUENCE; ANTIGENS, CD26; B-LYMPHOCYTES; CELL LINE; HIV ENVELOPE PROTEIN GP120; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; T-LYMPHOCYTES; VIRION;

EID: 0031569543     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Sylwestrowicz, T. A., D. D. Ma, P. P. Murphy, M. Massaia, H. G. Prentice, A. V. Hoffbrand, and M. F. Greaves. 1982. 5′Nucleotidase, adenosine deaminase and purine nucleoside phosphorylase activities in acute leukaemia. Leuk. Res. 6:475.
2. Vezzoni, P., R. Giardini, R. Lucchini, L. Lombardi, M. A. Vezzoni, C. Besana, and L. Clerici. 1985. Adenosine deaminase and terminal deoxynucleotidyl transferase in human lymphomas: an aid to the diagnosis and subclassification of lymphoblastic lymphomas. Am. J. Hematol. 19:219.
3. Murray, J. L., R. Perez-Soler, D. Bywaters, and E. M. Hersh. 1986. Decreased adenosine deaminase (ADA) and 5′nucleotidase (5NT) activity in peripheral blood T cells in Hodgkin disease. Am. J. Hematol. 21:57.
4. Vezzoni, P., F. Fiacchino, L. Clerici, A. Sghirlanzoni, D. Cerrato, D. Peluchetti, R. Lucchini, M. Raineri, and F. Cornelio. 1984. Studies on terminal deoxynucleotidyl transferase and adenosine deaminase in myasthenic thymus. J. Neuroimmunol. 6:427.
5. Lane, H. C., J. M. Depper, W. C. Greene, G. Whalen, T. A. Waldmann, and A. S. Fauci. 1985. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome: evidence for a selective defect in soluble antigen recognition. N. Engl. J. Med. 313:79.
6. Murray, J. L., K. C. Loftin, C. G. Munn, J. M. Reuben, P. W. Mansell, and E. M. Hersh. 1985. Elevated adenosine deaminase and purine nucleoside phosphorylase activity in peripheral blood null lymphocytes from patients with acquired immune deficiency syndrome. Blood 65:1318.
7. Hershfield, M. S., and B. S. Mitchell. 1995. Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. In The Metabolic and Molecular Bases of Inherited Disease, Vol. 2. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, eds. McGraw-Hill, New York, pp. 1725-68.
8. Aran, J. M., D. Colomer, E. Matutes, J. L. Vives-Corrons, and R. Franco. 1991. Presence of adenosine deaminase on the surface of mononuclear blood cells: immunochemical localization using light and electron microscopy. J. Histochem. Cytochem. 39:1001.
9. Andy, R. J., and R. Kornfeld. 1984. Biosynthesis of the adenosine deaminase-binding protein in human fibroblasts and hepatoma cells. J. Biol. Chem. 259:9832.
10. Kameoka, J., T. Tanaka, Y. Nojima, S. F. Schlossman, and C. Morimoto. 1993. Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science 261:466.
11. Fleischer, B. 1994. CD26: a surface protease involved in T-cell activation. Immunol. Today 15:180.
12. Torimoto, Y., N. H. Dang, E. Vivier, T. Tanaka, S. F. Schlossman, and C. Morimoto. 1991. Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. J. Immunol. 147:2514.
13. Mittrücker, H. W., C. Steeg, B. Malissen, and B. Fleischer. 1995. The cytoplasmic tail of the T cell receptor ζ chain is required for signaling via CD26. Eur. J. Immunol. 25:295.
14. Dong, R.-P., J. Kameoka, M. Hegen, T. Tanaka, Y. Xu, S. F. Schlossman, and C, Morimoto. 1996. Characterization of adenosine deaminase binding human CD26 on T cells and its biologic role in immune response. J. Immunol. 156:1349.
15. Martin, M., J. Huguet, J. J. Centelles, and R. Franco. 1995. Expression of ectoadenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. J. Immunol. 155:4630.
16. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cloning of a seven-transmembrane G protein-coupled receptor. Science 272:872.
17. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661.
18. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667.
19. Doranz, B., J. Rucker, Y. Yi, R. J. Smyth, M. Samson, S. C. Peiper, N. Parmentier, R. G. Collman, and R. W. Doms. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149.
20. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, M. Newman, N. Gerard, and J. Sodroski. 1996. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135.
21. Bleul, C. C., M. Farzan, H. Choe, C. Parolin, I. Clark-Lewis, J. Sodroski, and T. A. Springer. 1996. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382:829.
22. Oberlin, E., A. Amara, F. Bachelerie, C. Bessia, J. L. Virelizier, F. Arenzana-Seisdedos, O. Schwartz, J. M. Heard, I. Clark-Lewis, D. F. Legler, N. Loetscher, M. Bagglioni, and B. Moser. 1996. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382:833.
23. Oravecz, T., M. Pall, and M. A. Norcross. 1996. β-Chemokine inhibition of monocytotropic HIV-1 infection: interference with a postbinding fusion step. J. Immunol. 157:1329.
24. Oravecz, T., G. Roderiquez, J. Koffi, J. Wang, M. Ditto, D. C. Bou-Habib, P. Lusso, and M. A. Norcross. 1995. CD26 expression correlates with entry, replication and cytopathicity of monocytotropic HIV-1 strains in a T-cell line. Nat. Med. 1:919.
25. + cells. Science 262:2045.
26. Lazaro, I., D. Naniche, N. Signoret, A. M. Bernard, D, Marguet, D. Klatzmann, M. Alizon, and Q. Sattentau. 1994. Factors involved in entry of the human immunodeficiency virus type 1 into permissive cells: lack of evidence of a role for CD26. J. Virol. 68:6535.
27. Callebaut, C., E. Jacotot, B. Krust, and A. Hovanessian. 1994. CD26 antigen and HIV fusion? Science 264:1163.
28. Broder, C., O. Nussbaum, W. G. Gutheil, W. W. A. Bachovchin, E. A. Berger, C. Patience, C. A. McKnight, P. R. Clapham, M. T. Boyd, R. A. Weiss, T. F. Schultz, D. Camerini, D. V. Planelles, I. S. Y. Chen, M. Alizon, and T. Dragic. 1994. CD26 antigen and HIV fusion? Science 264:1156.
29. Morimoto, C., C. I. Lord, C. Zhang, J. S. Duke-Cohan, N. L. Letvin, and S. F. Schlossman. 1994. Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis. Proc. Natl. Acad. Sci. USA 91:9960.
30. De Pasquale, A., L. Ginaldi, P. Limoncelli, and D. Quaglino. 1989. Dipeptidyl amino peptidase IV cytochemistry in circulating lymphocytes from HIV-1-sero-positive subjects. Acta Haematol. 81:19.
31. Valle Blazquez, M., J. A. Madueño, R. Gonzalez, R. Jurado, W. W. Bachovchin, J. Peña, and E. Muñoz. 1992. Selective decrease of CD26 expression in T cells from HIV-1-infected individuals. J. Immunol. 149:3073.
32. + T lymphocytes of HIV-infected subjects. J. AIDS 6:749.
33. + T cell subset during HIV infection. Res. Immunol. 147:5.
34. + T cells. Virology 223:318.
35. Callebaut, C., and A. G. Hovanessian. 1996. CD26 and HIV infection. Res. Virol. 147:67.
36. Chin, L. T., M. Duenas, M. Levi, J. Hinkula, B. Wahren, and C. A. K. Borrebaek. 1995. Molecular characterization of a human anti-HIV monoclonal antibody revealed a CD26-related motif in CDR2. Immunol. Lett. 44:25.
37. Tanaka, T., J. Kameoka, A. Yaron, S. F. Schlossman, and C. Morimoto. 1993. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proc. Natl. Acad. Sci. USA 90:4586.
38. Blanco, J., I. Marié, E. Jacotot, C. Callebaut, B. Krust, and A. G. Hovanessian. 1996. Specific binding of adenosine deaminase but not HIV-1 transactivator protein Tat to human CD26. Exp. Cell Res. 225:102.
39. Linsley, P. S., J. A. Ledbetter, E. Kinney-Thomas, and S. L. Hu. 1988. Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1. J. Virol. 62:3695.
40. Laurent-Crawford, A. G., and A. G. Hovanessian. 1993. The cytopathic effect of human immunodeficiency virus is independent of high levels of unintegrated viral DNA accumulated in response to superinfection of cells. J. Gen. Virol. 74:2619.
41. Laurent-Crawford, A. G., B. Krust, S. Muller, Y. Rivière, M. A. Rey-Cuillé, J. M. Béchet, L. Montagnier, and A. G. Hovanessian. 1991. The cytopathic effect of HIV is associated with apoptosis. Virology 185:829.
42. Blanco, J., E. I. Canela, J. Mallol, C. Lluis, and R. Franco. 1992. Characterization of adenosine receptors in brush-border membranes from pig kidney. Br. J. Pharmacol. 107:671.
43. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
44. Ou, C. Y., S. Kwok, S. W. Mitchell, D. H. Mack, J. J. Sninsky, J. W. Krebs, P. Feorino, D. Warfield, and G. Schochetman. 1988. DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. [Published erratum appears in 1988 Science 240:240]. Science 239:295
45. Lawn, R. M., A. Efstratiadis, C. O'Connell, and T. Maniatis. 1980. The nucleotide sequence of the human beta-globin gene. Cell 21:647.
46. Sattentau, Q. J., and R. A. Weiss. 1988. The CD4 antigen: physiological ligands and HIV receptor. Cell 52:631.
47. Wang, Y. H., A. H. Davies, and I. M. Jones. 1995. Expression and purification of glutathione S-transferase-tagged HIV-1 gp120: no evidence of an interaction with CD26. Virology 208:142.
48. De Meester, I., G. Vanham, L. Kestens, G, Vanhoof, E, Bosmans, P. Gigase, and S. Scharpe. 1994. Binding of adenosine deaminase to the lymphocyte surface via CD26. Eur. J. Immunol. 24:566.
49. Wu, L., N. P. Gerard, R. Wyatt, H. Choe, C. Parolin, N. Ruffing, A. Borsetti, A. A. Cardoso, E. Desjardin, W. Newman, C. Gerard, and J. Sodroski. 1996. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384:179.
50. Trkola, A., T. Dragic, J. Arthos, J. M. Binley, W. C. Olson, G. P. Allaway, C. Cheng-Mayer, J. Robinson, P. J. Maddon, and J. P. Moore. 1996. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 384:184.
51. Lasky, A., G. Nakamura, D. H. Smith, C. Fennie, E. Shimasaki, E. Patzer, P. Berman, T. Gregory, and D. J. Capon. 1987. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with CD4 receptor. Cell 50:975.
52. + T cells in patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. Ann. Intern. Med. 113:438.
53. Piatak, J. M., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K.-C. Luk, B. H. Hahn, G. M. Shaw, and J. D. Lifson. 1993. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749.
54. Martínez-Hernández, D., J. Arenas-Barbero, F. Navarro-Gallar, R. García-Esteban, and F. J. Gómez-de-Terreros. 1988. Adenosine deaminase in the acquired immunodeficiency syndrome. Clin. Chem. 34:1949.